Sentio BioSciences invests $10.6M to expand pharmaceutical manufacturing facility in Missouri
Sentio BioSciences has announced plans to expand its pharmaceutical manufacturing facility in Maryland Heights, Missouri. The company, which produces new and generic drugs, has invested more than $10.6 million into the project and is creating 58 new jobs.
The expansion will increase Sentio’s manufacturing capacity for essential generic medicines, including key starting materials, Active Pharmaceutical Ingredients (API), and drug products. The new manufacturing space is set to open in 2026 and will also support contract development and manufacturing services for both emerging and established life sciences companies across Missouri and the U.S. Sentio’s facilities emphasize quality, safety, and on-time delivery, and the company recently earned OSHA’s SHARP certification, recognizing its excellence in worksite safety and health. The project is supported by the Missouri Works program, which provides access to capital through withholdings or tax credits tied to job creation.
What people are saying
In a recent quote, Karthik Raghavan, CEO, Sentio BioSciences, said, “Sentio has been a strong advocate for manufacturing essential medicines in the United States, emphasizing high quality, secure and reliable supply. This expansion announcement shows our continued commitment and builds on our successful track record for manufacturing essential medicines domestically.”
Mike Kehoe, Governor of Missouri, added, “The St. Louis region stands out as a leading location for cutting-edge employers like Sentio BioSciences. This Missouri-made company’s emphasis on innovation and safety aligns perfectly with our strengths in science, technology, and manufacturing. We congratulate Sentio BioSciences and look forward to its ongoing success.”
Manufacturers investing in Missouri
Triad Manufacturing invests $1.78M to expand custom retail display manufacturing facility in Missouri
The expanded operations will help Triad Manufacturing meet growing demand while adding 32 new jobs in the region.
Nortian Foodtech invests $22.2M to build protein manufacturing facility in Missouri
The 160,000-square-foot manufacturing facility will transform meat byproducts into high-quality food-grade ingredients.
Ingredient manufacturer spends $70 million to open facility in Missouri
The company invested $70 million to build the 38,000-square-foot facility and generated 30 new jobs.
Investing in American manufacturing in 2025
This map shows where manufacturers are choosing to invest their resources, whether they are building new production facilities or expanding existing plants.